Resumen
Introducción: el vitíligo genital femenino afecta la piel de la vulva y puede cursar aislado o generalizado. Objetivo: identificar la magnitud de la afectación de la calidad de vida (CV), sus consecuencias, la carga psicosocial y el impacto que genera el vitíligo con compromiso genital. Método: se diseñó un estudio descriptivo con mujeres adultas con vitíligo genital y residentes en el caribe colombiano. Se evaluó CV, sus consecuencias, carga psicosocial e impacto del vitíligo con Dermatology Life Quality Index y Vitiligo Impact Scale. Resultados: participaron 78 mujeres, edad: 46,8±12,5. El 69,2% fue “grande” o “extremadamente grande” en afectación de la CV y en el 79% a consecuencia de la limitación en las relaciones interpersonales o en la sexualidad y en el 97,4% fue alto el impacto psicosocial en la afectación de la CV. Conclusiones: el vitiligo genera alto impacto y gran magnitud en la afectación en la CV en mujeres.Citas
Walker M. Human skin through the ages. Int J Pharm. 2022;622:121850. https://doi.org/10.1016/j.ijpharm.2022.121850
Salama AH, Alnemr L, Khan AR, Alfakeer H, Aleem Z, Ali-Alkhateeb M. Unveiling the Unseen Struggles: A Comprehensive review of vitíligo's psychological, social, and quality of life impacts. Cureus. 2023;15:e45030. https://doi.org/10.7759/cureus.45030
Bergqvist C, Ezzedine K. Vitíligo: A review. Dermatology. 2020;236:571-592. https://doi.org/10.1159/000506103
Sarhan D, Mohammed GF, Gomaa AH, Eyada MM. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with vitíligo with and without genital affection. J Sex Marital Ther. 2016;42:267-276 https://doi.org/10.1080/0092623X.2015.1010678
Picardo M, Huggins RH, Jones H, Marino R, Ogunsola M, Seneschal J. The humanistic burden of vitíligo: A systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol. 2022;36:1507-1523. https://doi.org/10.1111/jdv.18129
Liang X, Guo F, Cai X, Wang J, Chen J, Liu L, et al. Association between vitíligo and sexual dysfunction: current evidence. Ann Med. 2023;55:946-953. https://doi.org/10.1080/07853890.2023.2182906
Wu JH, Cohen BA. The stigma of skin disease. Curr Opin Pediatr. 2019;31:509-514. https://doi.org/10.1097/MOP.0000000000000792
Roman J. Beauty That Is more than skin deep. JAMA Dermatol. 2016;152:562-563. https://doi.org/10.1001/jamadermatol.2015.4762
Amer AA, Gao XH. Quality of life in patients with vitíligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55:608-614. https://doi.org/10.1111/ijd.13198
Maamri A, Badri T. Sexual disorders in patients with vitíligo. Tunis Med. 2021;99(5):504-505.
Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Vitíligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitíligo and related issues: the Vitíligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1-13. https://doi.org/10.1111/j.1755-148X.2012.00997
Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the Vitíligo Impact Scale-22 (VIS-22), a vitíligo-specific quality-of-life instrument. Br J Dermatol. 2014;171:1084-1090. https://doi.org/10.1111/bjd.13093
Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573-577.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol. 2005;125:659-664. https://doi.org/10.1111/j.0022-202X.2005.23621.x
Krüger C, Schallreuter KU. Cumulative life course impairment in vitíligo. Curr Probl Dermatol. 2013;44:102-117. https://doi.org/10.1159/000350010
Rencz F, Gergely LH, Wikonkál N, Gáspár K, Péntek M, Gulácsi L, et al. Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI-Relevant (DLQI-R) scoring. J Eur Acad Dermatol Venereol. 2020;34:e484-486. https://doi.org/10.1111/jdv.16398
De Tiedra A, Mercadal J, Badia X, Mascaro JM, Herdman M, Lozano R. Transcultural adaptation of the questionnaire Dermatology Life Quality Index (DLQI): El Índice de Calidad de Vida en Dermatología. Actas Dermosifiliogr. 1998;89:692-700.
Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitíligo impact scale: an instrument to assess the psychosocial burden of vitíligo. Indian J Dermatol Venereol Leprol. 2013;79:205-210. https://doi.org/10.4103/0378-6323.107637
Gupta V, Sreenivas V, Mehta M, Ramam M. What do vitíligo impact scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2019;180:580-585. https://doi.org/10.1111/bjd.17040
Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Ballanger F, et al. Living with vitíligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173:607-609. https://doi.org/10.1111/bjd.13839
Elbuluk N, Ezzedine K. Quality of Life, burden of disease, co-morbidities, and systemic effects in vitíligo patients. Dermatol Clin. 2017;35:117-128. https://doi.org/10.1016/j.det.2016.11.002
Silverberg JI, Silverberg NB. Association between vitíligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149:159-164. https://doi.org/10.1001/jamadermatol.2013.927
Peralta-Pedrero ML, Guerrero-Oliva G, Morales-Sánchez MA, Chirino-Castillo GQ, Marín-Rivera D, et al. What is the quality of life of adults with vitíligo in Mexico? Gac Med Mex. 2022;158:393-400 https://doi.org/10.24875/GMM.M22000718
Ongenae K, Beelaert L, van Geel N, Naeyaert JM. Psychosocial effects of vitíligo. J Eur Acad Dermatol Venereol. 2006;20:1-8. https://doi.org/10.1111/j.1468-3083.2005.01369.x
Bhandarkar SS, Kundu RV. Quality-of-life issues in vitíligo. Dermatol Clin. 2012;30:255-268. https://doi.org/10.1016/j.det.2011.11.013
Morrison B, Burden-Teh E, Batchelor JM, Mead E, Grindlay D, Ratib S. Quality of life in people with vitíligo: a systematic review and meta-analysis. Br J Dermatol. 2017;177:e338-339. https://doi.org/10.1111/bjd.15933
Sukan M, Maner F. The problems in sexual functions of vitíligo and chronic urticaria patients. J Sex Marital Ther. 2007;33:55-64. https://doi.org/10.1080/00926230600998482
Fatani MI, Aldhahri RM, Al Otaibi HO, Kalo BB, Khalifa MA. Acknowledging popular misconceptions about vitíligo in western Saudi Arabia. J Dermatol Dermatologic Surg. 2016;20:27-31. https://doi.org/10.1016/j.jdds.2015.09.001
Osinubi O, Grainge MJ, Hong L, Ahmed A, Batchelor JM, Grindlay D, et al. The prevalence of psychological comorbidity in people with vitíligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178:863-878. https://doi.org/10.1111/bjd.16049
Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitíligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177:708-718. https://doi.org/10.1111/bjd.15199
Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitíligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2018;32:1343-1351. https://doi.org/10.1111/jdv.14739
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitíligo. Lancet. 2015;386:74-84. https://doi.org/10.1016/S0140-6736(14)60763-7
Krüger C, Schallreuter KU. Cumulative life course impairment in vitíligo. Curr Probl Dermatol. 2013;44:102-117. https://doi.org/10.1159/000350010
Morales-Sánchez MA, Vargas-Salinas M, Peralta-Pedrero ML, Olguín-García MG, Jurado-Santa Cruz F. Impacto del vitíligo en la calidad de vida. Actas Dermo-Sifiliográficas 2017;108:637-642. https://doi.org/10.1016/j.ad.2017.03.007
Salzes C, Abadie S, Seneschal J, Whitton M, Meurant JM, Jouary T, et al. The Vitíligo Impact Patient Scale (VIPs): Development and validation of a Vitíligo Burden Assessment Tool. J Invest Dermatol. 2016;136:52-58. https://doi.org/10.1038/JID.2015.398
Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. https://doi.org/10.1097/00005650-199603000-00003
Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitíligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69:e11-18. https://doi.org/10.1016/j.jaad.2012.01.038
Rzepecki AK, McLellan BN, Elbuluk N. Beyond traditional treatment: the importance of psychosocial therapy in vitíligo. J Drugs Dermatol. 2018;17:688-691
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Derechos de autor 2024 Universidad del Magdalnea